{
    "code": "01048925",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=01048925",
    "time": "2021-11-12 03:08:33",
    "許可證字號": "衛署藥製字第048925號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "111\/08\/02",
    "發證\/登錄日期": "96\/08\/02",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY00104892501",
    "中文品名": "可多舒明點眼液",
    "英文品名": "Co-Dorzomide Ophthalmic Solution",
    "適應症": "高眼壓症、開放性青光眼、假性剝離性青光眼所造成之眼內壓升高。",
    "劑型": "472點眼液劑",
    "包裝": "100ml以下塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "TIMOLOL MALEATE, DORZOLAMIDE HYDROCHLORIDE",
    "限制項目": "01國　產 24監視期滿學名藥",
    "申請商名稱": "620118D651  麥迪森醫藥股份有限公司",
    "申請商地址": "臺北市中正區林森南路10號5樓",
    "主製造廠": [
        {
            "": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1216001910",
            "成分名稱": "TIMOLOL MALEATE",
            "含量描述": "(equivalent to Timlol 5mg)",
            "含量": "6.8300000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "9200036410",
            "成分名稱": "DORZOLAMIDE HYDROCHLORIDE",
            "含量描述": "(equivalent to Dorzolamide 20mg)",
            "含量": "22.3000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "可多舒明點眼液套標5B34-4-110-03-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=003&Type=10"
        },
        {
            "title": "可多舒敏-套標-106-06-28(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=002&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "可多舒明點眼液(衛署藥製字第048925號)-110-09-17.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=010&Type=9"
        },
        {
            "title": "可多舒明點眼液仿單5A39-6-110-03-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=009&Type=9"
        },
        {
            "title": "01048925_麥迪森_可多舒明點眼液_仿單-108-09-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=008&Type=9"
        },
        {
            "title": "麥迪森可多舒明點眼液 說明書 1070703-107-09-14(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=007&Type=9"
        },
        {
            "title": "可多舒明點眼液彩盒5F41-5-110-03-10(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=010&Type=8"
        },
        {
            "title": "01048925_麥迪森_可多舒明點眼液_標籤外盒-108-09-05.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=009&Type=8"
        },
        {
            "title": "可多舒明5ml標籤3-2015.09.22-106-07-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=008&Type=8"
        },
        {
            "title": "可多舒明彩盒4-106-07-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=01048925&Seq=007&Type=8"
        }
    ]
}